FDA Issues Strict Limits on Johnson & Johnson Covid 19 Vaccines

A nurse gives a girl a dose of the Pfizer vaccine at a COVID-19 vaccine clinic at Lyman High School in Longwood on the day before classes begin for the 2021-22 school year. (Photo by Paul Hennessy/SOPA Images/LightRocket via Getty Images via Fox News)

On Thursday, The Food and Drug Administration issued strict limits on Johnson & Johnson COVID-19 vaccines.

The limits on the “one-shot” follow reports of blood clots due to the J&J vaccine. FDA’s Vaccine Chief Dr. Peter Marks stated that the agency decided to restrict the vaccine after reviewing the data on the risks of “life-threatening,” but rare, blood clots and concluding the blood clots are limited to the J&J vaccine.

FDA is limiting the vaccine to individuals 18 years old and older who cannot take any other COVID-19 vaccine due to accessibility or medical reasons.

Meanwhile, the Centers of Disease Control and Prevention are recommending, for those who are currently unvaccinated, to get the mRNA or commonly known as the standard two dose vaccine series, such as Moderna or Pfizer over the matching J&J vaccine because of the same safety concerns.